Revenue Recognition (Tables)
|
12 Months Ended |
Dec. 31, 2019 |
| Revenue Recognition |
|
| Schedule of disaggregation of revenue by test families |
| | | | | | | | | | | | Year Ended December 31, | | | 2019 | | 2018 | | 2017 | (Amounts in thousands) | | | | | | | | Product revenues | | | | | | | | | | Sale of genetic tests | | $ | 269,881 | | $ | 240,366 | | $ | 203,777 | Licensing and other | | | | | | | | | | Upfront license and Constellation and paternity | | | 5,089 | | | 10,344 | | | 4,229 | License and development services | | | 16,379 | | | 294 | | | — | Other | | | 10,979 | | | 6,650 | | | 1,619 | Licensing and other revenues | | | 32,447 | | | 17,288 | | | 5,848 | Total revenues | | $ | 302,328 | | $ | 257,654 | | $ | 209,625 |
|
| Schedule of disaggregation of revenue by payer types |
| | | | | | | | | | | | Year Ended December 31, | | | 2019 | | 2018 | | 2017 | (Amounts in thousands) | | | | | | | | Insurance carriers | | $ | 210,919 | | $ | 193,895 | | $ | 163,861 | Laboratory partners | | | 59,876 | | | 44,062 | | | 36,001 | Patients | | | 31,533 | | | 19,697 | | | 9,763 | Total revenues | | $ | 302,328 | | $ | 257,654 | | $ | 209,625 |
|
| Schedule of total revenue by geographic area |
| | | | | | | | | | | | Year ended December 31, | | | 2019 | | 2018 | | 2017 | (Amounts in thousands) | | | | | | | | United States | | $ | 260,846 | | $ | 225,931 | | $ | 185,533 | Americas, excluding U.S. | | | 3,218 | | | 3,472 | | | 3,028 | Europe, Middle East, India, Africa | | | 15,434 | | | 20,866 | | | 13,998 | Asia Pacific and Other | | | 22,830 | | | 7,385 | | | 7,066 | Total | | $ | 302,328 | | $ | 257,654 | | $ | 209,625 |
|
| Schedule of beginning and ending balances of accounts receivable and deferred revenues |
| | | | | | | | | Balance at | | Balance at | | | December 31, | | December 31, | | | 2019 | | 2018 | (Amounts in thousands) | | | | | Assets: | | | | | | | Accounts receivable | | $ | 53,351 | | $ | 62,223 | Liabilities: | | | | | | | Deferred revenue, current portion | | $ | 56,016 | | $ | 4,131 | Deferred revenue, long-term portion | | | 23,808 | | | 40,058 | Total deferred revenues | | $ | 79,824 | | $ | 44,189 |
|
| Schedule of changes in the balance of deferred revenues |
| | | | | | Deferred | | | Revenues | | | (in thousands) | Balance at December 31, 2018 | | $ | 44,189 | Increase in deferred revenues | | | 65,026 | Revenue recognized during the period that was included in deferred revenues at the beginning of the period | | | (970) | Revenue recognized from performance obligations satisfied within the same period | | | (23,209) | Transferred in the sale of business | | | (5,212) | Balance at December 31, 2019 | | $ | 79,824 |
|
| Schedule of insurance carrier reserve balance |
| | | | | | | | | December 31, | | December 31, | | | 2019 | | 2018 | | | | | | | | (Amounts in thousands) | | | | | | Beginning balance | | $ | 10,012 | | $ | 6,795 | Additional reserves | | | 9,560 | | | 10,295 | Reserves released | | | (10,162) | | | (7,078) | Ending balance | | $ | 9,410 | | $ | 10,012 | | | | | | | | Released into revenue | | $ | 2,410 | | $ | 3,324 |
|